tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Christopher Neyor, 1 are a HOLD (12.5%), 6 are a BUY (75%), 1 are a SELL (12.5%).
Analyst Christopher Neyor, carries an average stock price target met ratio of 44.44% that have a potential upside of 9.74% achieved within 82 days. Previously, Christopher Neyor worked at JPMORGAN, CREDIT SUISSE.
Christopher Neyor’s has documented 14 price targets and ratings displayed on 3 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on ITOS, Iteos Therapeutics at 13-May-2025.
Analyst best performing recommendations are on PCRX (PACIRA PHARMACEUTICALS).
The best stock recommendation documented was for ITOS (ITEOS THERAPEUTICS) at 5/13/2025. The price target of $8 was fulfilled within 6 days with a profit of $0.15 (1.91%) receiving and performance score of 3.18.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 07-Nov-2025
$32
$6.79 (26.93%)
$28
14 days ago
(23-Sep-2026)
1/9 (11.11%)
$7.37 (29.92%)
29
Hold Since 01-May-2026
$25
$-0.21 (-0.83%)
$24
2 months 2 days ago
(05-Aug-2026)
2/2 (100%)
$0.13 (0.52%)
3
Buy Since 30-Apr-2020
$33
$7.79 (30.90%)
$32
2 months 2 days ago
(05-Aug-2026)
11/32 (34.38%)
$8.13 (32.69%)
261
Buy Since 21-Mar-2017
$38
$12.79 (50.73%)
$38
3 months 6 days ago
(01-Jul-2026)
8/15 (53.33%)
$12.97 (51.82%)
518
Hold Since 26-Mar-2026
$25
$-0.24 (-0.95%)
$18
6 months 11 days ago
(26-Mar-2026)
2/6 (33.33%)
$1.69 (7.25%)
50
